Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Evotec AG

BRIEF

published on 05/28/2024 at 07:35, 5 months 24 days ago

Evotec and CHDI Foundation Extend Collaboration on Huntington’s Disease Research

Drug Discovery Collaboration Evotec CHDI Foundation Huntington’s Disease
PRESS RELEASE

published on 05/28/2024 at 07:30, 5 months 24 days ago

Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Evotec SE extends strategic drug discovery collaboration with CHDI Foundation in Huntington's disease, emphasizing commitment to developing new therapies and improving patients' lives

Drug Discovery Evotec SE Therapeutics CHDI Foundation Huntington's Disease
BRIEF

published on 05/22/2024 at 07:05, 5 months 30 days ago

Evotec Reports Challenging Q1 2024 Results and Strategic Updates

Financial Results Q1 2024 Evotec Strategic Updates Biologics Growth
PRESS RELEASE

published on 05/22/2024 at 07:00, 5 months 30 days ago

Evotec reports Q1 2024 results and provides corporate update
Evotec SE reports Q1 2024 financial results and corporate update, outlines growth in Just - Evotec Biologics and challenges in transactional business. New CEO and CPO appointments. Group revenues expected to grow double-digit in FY 2024

Financial Results Evotec SE CEO Appointment Q1 2024 Just - Evotec Biologics
BRIEF

published on 05/15/2024 at 12:05, 6 months 6 days ago

Evotec SE to Announce Q1 2024 Financial Results on May 22

Financial Results Conference Call Biotechnology Evotec SE Q1 2024
PRESS RELEASE

published on 05/15/2024 at 12:00, 6 months 6 days ago

Evotec SE to announce results for first quarter 2024 on 22 may 2024
Evotec SE to announce financial results for the first quarter of 2024 on May 22, 2024, holding a conference call in English to discuss performance updates

Financial Results Conference Call Evotec SE First Quarter 2024 Performance Update
BRIEF

published on 04/30/2024 at 08:35, 6 months 21 days ago

Bayer and Evotec Focus on Advancing Precision Cardiology

Innovation Partnership Cardiovascular Diseases Precision Cardiology IPSCs
PRESS RELEASE

published on 04/30/2024 at 08:30, 6 months 21 days ago

Bayer and Evotec collaborate to advance precision cardiology
Bayer and Evotec collaborate to advance precision cardiology, focusing on innovative therapies for cardiovascular diseases. The strategic alliance aims to leverage human induced pluripotent stem cells for novel targets

Cardiovascular Diseases Bayer Strategic Collaboration Evotec Precision Cardiology
BRIEF

published on 04/24/2024 at 07:05, 6 months 27 days ago

Evotec Announces 2023 Fiscal Year Results and Strategic Refocus

Financial Results Strategic Partnerships Evotec SE Profitable Growth Fiscal Year 2023
PRESS RELEASE

published on 04/24/2024 at 07:00, 6 months 27 days ago

Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
Evotec SE announces fiscal year 2023 results with focus on profitable growth. Priority reset to drive annual EBITDA improvement greater than €40m. New reporting structure planned for Q1 2024

Evotec SE Profitable Growth Fiscal Year 2023 Annual EBITDA Improvement Reporting Structure

Accesswire

Published on 11/22/2024 at 00:00, 6 hours 25 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 8 hours 20 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 35 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 10 hours 10 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 10 hours 15 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 11 hours 24 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 49 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 12 hours 26 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 12 hours 33 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours 33 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 23 hours 27 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 11 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 22 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE